Fibroblast growth factor 23: state of the field and future directions

被引:110
作者
Bhattacharyya, Nisan [1 ]
Chong, William H. [1 ]
Gafni, Rachel I. [1 ]
Collins, Michael T. [1 ]
机构
[1] Natl Inst Dent & Craniofacial Res, Skeletal Clin Studies Unit, Craniofacial & Skeletal Dis Branch, NIH, Bethesda, MD USA
基金
美国国家卫生研究院;
关键词
TUMOR-INDUCED OSTEOMALACIA; CHRONIC KIDNEY-DISEASE; VITAMIN-D METABOLISM; HYPEROSTOSIS-HYPERPHOSPHATEMIA SYNDROME; AUTOSOMAL RECESSIVE HYPOPHOSPHATEMIA; HOMOZYGOUS MISSENSE MUTATION; X-LINKED HYPOPHOSPHATEMIA; RENAL PHOSPHATE-TRANSPORT; MCCUNE-ALBRIGHT-SYNDROME; PARATHYROID-HORMONE;
D O I
10.1016/j.tem.2012.07.002
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Fibroblast growth factor 23 (FGF23) is a bone-derived hormone that regulates and is regulated by blood levels of phosphate and active vitamin D. Post-translational glycosylation by the enzyme GALNT3 and subsequent processing by furin have been demonstrated to be a regulated process that plays a role in regulating FGF23 levels. In physiologic states, FGF23 signaling is mediated by an FGF receptor and the coreceptor, Klotho. Recent work identifying a role for iron/hypoxia pathways in FGF23 physiology and their implications are discussed. Beyond its importance in primary disorders of mineral metabolism, recent work implicates FGF23 in renal disease-associated morbidity, as well as possible roles in cardiovascular disease and skeletal fragility.
引用
收藏
页码:610 / 618
页数:9
相关论文
共 99 条
[1]
Calcimimetics as an adjuvant treatment for familial hypophosphatemic rickets [J].
Alon, Uri S. ;
Levy-Olomucki, Rachel ;
Moore, Wayne V. ;
Stubbs, Jason ;
Liu, Shiguang ;
Quarles, L. Darryl .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2008, 3 (03) :658-664
[2]
Dietary phosphorus regulates serum fibroblast growth factor-23 concentrations in healthy men [J].
Antoniucci, Diana M. ;
Yamashita, Takeyoshi ;
Portale, Anthony A. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (08) :3144-3149
[3]
1,25-dihydroxyvitamin D3/VDR-mediated induction of FGF23 as well as transcriptional control of other bone anabolic and catabolic genes that orchestrate the regulation of phosphate and calcium mineral metabolism [J].
Barthel, Thomas K. ;
Mathern, Douglas R. ;
Whitfield, G. Kerr ;
Haussler, Carol A. ;
Hopper, H. Andrew ;
Hsieh, Jui-Cheng ;
Slater, Stephanie A. ;
Hsieh, Grace ;
Kaczmarska, Magdalena ;
Jurutka, Peter W. ;
Kolek, Olga I. ;
Ghishan, Fayez K. ;
Haussler, Mark R. .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2007, 103 (3-5) :381-388
[4]
Effect of fibroblast growth factor-23 on phosphate transport in proximal tubules [J].
Baum, M ;
Schiavi, S ;
Dwarakanath, V ;
Quigley, R .
KIDNEY INTERNATIONAL, 2005, 68 (03) :1148-1153
[5]
BELL NH, 1985, NEW ENGL J MED, V313, P1418
[6]
BELL NH, 1993, J BONE MINER RES, V8, P1111
[7]
The parathyroid is a target organ for FGF23 in rats [J].
Ben-Dov, Iddo Z. ;
Galitzer, Hillel ;
Lavi-Moshayoff, Vardit ;
Goetz, Regina ;
Kuro-o, Makoto ;
Mohammadi, Moosa ;
Sirkis, Roy ;
Naveh-Many, Tally ;
Silver, Justin .
JOURNAL OF CLINICAL INVESTIGATION, 2007, 117 (12) :4003-4008
[8]
An FGF23 missense mutation causes familial tumoral calcinosis with hyperphosphatemia [J].
Benet-Pagès, A ;
Orlik, P ;
Strom, TM ;
Lorenz-Depiereux, B .
HUMAN MOLECULAR GENETICS, 2005, 14 (03) :385-390
[9]
Defective O-Glycosylation due to a Novel Homozygous S129P Mutation Is Associated with Lack of Fibroblast Growth Factor 23 Secretion and Tumoral Calcinosis [J].
Bergwitz, Clemens ;
Banerjee, Santanu ;
Abu-Zahra, Hilal ;
Kaji, Hiroshi ;
Miyauchi, Akimitsu ;
Sugimoto, Toshitsugu ;
Jueppner, Harald .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 94 (11) :4267-4274
[10]
Evidence for a signaling axis by which intestinal phosphate rapidly modulates renal phosphate reabsorption [J].
Berndt, Theresa ;
Thomas, Leslie F. ;
Craig, Theodore A. ;
Sommer, Stacy ;
Li, Xujian ;
Bergstralh, Eric J. ;
Kumar, Rajiv .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (26) :11085-11090